Thyroid Eye Disease (TED), or Graves' Ophthalmopathy, is an autoimmune orbitopathy that inflames and remodels orbital tissues, often leading to visually impactful conditions like proptosis, diplopia, and severe dry eye. While endocrinologists and ophthalmologists manage the primary medical and surgical treatment, optometrists are essential partners in care, frequently serving as the first point of diagnosis and providing long-term supportive management. The critical role of the optometrist involves counseling on key lifestyle and nutritional modifications—strategies backed by peer-reviewed evidence—to mitigate symptoms, reduce inflammation, and optimize patient response to conventional therapy. The most impactful intervention an optometrist can counsel a TED patient on is smoking cessation [1]. This habit is unequivocally the most significant modifiable risk factor, drastically increasing the risk and severity of TED and actively diminishing the efficacy of medical t...